TY - JOUR
T1 - Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema
AU - Moshfeghi, Andrew A.
AU - Scott, Ingrid U.
AU - Flynn, Harry W.
AU - Puliafito, Carmen A.
N1 - Funding Information:
Supported in part by Research to Prevent Blindness, Inc., New York, New York.
Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2004/9
Y1 - 2004/9
N2 - Purpose To report pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema. Design Retrospective, noncomparative, consecutive case series. Methods Records were reviewed of all patients who developed pseudohypopyon after intravitreal triamcinolone acetonide injection at Bascom Palmer Eye Institute between January 1, 2002 and February 1, 2004. Results A total of 828 intravitreal triamcinolone acetonide injections were administered to 686 patients during the study period. A pseudohypopyon (fine white crystalline opacities in the inferior anterior chamber angle) and suspended white crystalline opacities in the aqueous humor developed after 7 of the 828 injections (0.8%); all pseudohypopyons occurred within 3 days of injection and resolved completely within 2 weeks. None of the 686 patients developed clinically suspected infectious endophthalmitis. Conclusions A transient pseudohypopyon may occur in the early postinjection period after intravitreal triamcinolone acetonide injection. Unless progressive intraocular inflammation occurs, close observational management is indicated.
AB - Purpose To report pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema. Design Retrospective, noncomparative, consecutive case series. Methods Records were reviewed of all patients who developed pseudohypopyon after intravitreal triamcinolone acetonide injection at Bascom Palmer Eye Institute between January 1, 2002 and February 1, 2004. Results A total of 828 intravitreal triamcinolone acetonide injections were administered to 686 patients during the study period. A pseudohypopyon (fine white crystalline opacities in the inferior anterior chamber angle) and suspended white crystalline opacities in the aqueous humor developed after 7 of the 828 injections (0.8%); all pseudohypopyons occurred within 3 days of injection and resolved completely within 2 weeks. None of the 686 patients developed clinically suspected infectious endophthalmitis. Conclusions A transient pseudohypopyon may occur in the early postinjection period after intravitreal triamcinolone acetonide injection. Unless progressive intraocular inflammation occurs, close observational management is indicated.
UR - http://www.scopus.com/inward/record.url?scp=4444235582&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=4444235582&partnerID=8YFLogxK
U2 - 10.1016/j.ajo.2004.03.025
DO - 10.1016/j.ajo.2004.03.025
M3 - Article
C2 - 15364241
AN - SCOPUS:4444235582
VL - 138
SP - 489
EP - 492
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
SN - 0002-9394
IS - 3
ER -